FIELD: organic chemistry, pharmacy. SUBSTANCE: invention describes novel compounds as retinoids of the general formula (I) where X means oxo-group or group OR1 in position 4 or 5; R1 means hydrogen atom and R2 means hydrogen atom or alkyl; bonds designated by dotted line are optional ones and 3,4-double bond can present only in the case when X is at position 5, and also pharmaceutically acceptable carboxylic acid salts of compounds of the formula (I). Invention describes also a pharmaceutical composition containing compounds indicated above. Retinoids and retinoid-based pharmaceutical composition can be used for treatment and prophylaxis of patients with skin diseases accompanying with epithelium alternations, for treatment of acne and psoriasis and malignant and precancer pathological alternations of epithelium also, tumor and pretumor alternations of mouth, tongue, larynx, esophagus, bladder, uterine cervix and colon membrane mucosa. EFFECT: new compounds indicated above, valuable anticancer properties of compounds. 17 cl
Title | Year | Author | Number |
---|---|---|---|
RETINOID | 1996 |
|
RU2166499C2 |
NOVEL POLYUNSATURATED COMPOUNDS, METHOD OF THEIR OBTAINING AND COMPOSITIONS WHICH CONTAIN THEM | 2006 |
|
RU2466988C2 |
AROMATIC DERIVATIVES OF CARBOXYLIC ACID AND A PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2130009C1 |
RETINOIC ACID X-RECEPTOR LIGANDS | 1995 |
|
RU2146241C1 |
TRIAZOLO (4,3-a) 1,4 BENZO DIAZEPINES AND THRENO (3,2 | 1992 |
|
RU2094436C1 |
ANALOGS OF VITAMIN D, PHARMACEUTICAL COMPOSITION | 1997 |
|
RU2173682C2 |
COMPOUNDS FOR TARGETED DELIVERY OF MEDICINE AND ENHANCED SIPHK ACTIVITY | 2012 |
|
RU2632888C2 |
NOVEL RETINOIDS FOR EMPHYSEMA TREATMENT | 2001 |
|
RU2282616C2 |
4-HYDROXYPIPERIDINE DERIVATIVES | 1997 |
|
RU2178412C2 |
3-OXO-3,9-DIHYDRO-1H-CHROMENO[2,3-c] PYRROLES AS GLUCOKINASE ACTIVATORS | 2011 |
|
RU2603191C2 |
Authors
Dates
2001-09-20—Published
1997-04-15—Filed